Clearside Biomedical, Inc.
US ˙ OTCPK

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Bradford T Whitmore. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação
Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Bradford T Whitmore reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ULBI / Ultralife Corporation Director, 10% Owner 2,050,637
US:SLSN / Solesence, Inc. 10% Owner 18,669,879
US:CLSD / Clearside Biomedical, Inc. 10% Owner 4,495,034
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Bradford T Whitmore. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas CLSDQ / Clearside Biomedical, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CLSDQ / Clearside Biomedical, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Máx		 Preço em
Máx		 Lucro
Máx ($)		 Retorno Máx (%)
2024-02-07 CLSD WHITMORE BRADFORD T 444,444 1.3500 29,630 20.2500 599,999 33 2.0200 -540,148 -90.02
2023-11-01 CLSD WHITMORE BRADFORD T 64,366 0.7442 4,291 11.1630 47,901
2023-10-31 CLSD WHITMORE BRADFORD T 70,812 0.7278 4,721 10.9170 51,537
2023-10-30 CLSD WHITMORE BRADFORD T 600 0.6850 40 10.2750 411
2021-01-06 CLSD WHITMORE BRADFORD T 350,750 2.8510 23,383 42.7650 999,988
2020-12-24 CLSD WHITMORE BRADFORD T 51,195 1.9513 3,413 29.2695 99,897
2020-12-02 CLSD WHITMORE BRADFORD T 53,900 1.9490 3,593 29.2350 105,051
2020-11-24 CLSD WHITMORE BRADFORD T 62,000 1.6459 4,133 24.6885 102,046
2020-11-16 CLSD WHITMORE BRADFORD T 62,000 1.6924 4,133 25.3860 104,929
2020-08-13 CLSD WHITMORE BRADFORD T 50,000 1.6512 3,333 24.7680 82,560
2020-08-12 CLSD WHITMORE BRADFORD T 300,000 1.6304 20,000 24.4560 489,120

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CLSDQ / Clearside Biomedical, Inc. Insider Trades
Vendas Internas CLSDQ / Clearside Biomedical, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CLSDQ / Clearside Biomedical, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
2021-09-01 CLSD WHITMORE BRADFORD T 213,203 6.8913 14,214 103.3695 1,469,246 265 1.3000 -1,450,768 -98.74
2021-08-31 CLSD WHITMORE BRADFORD T 107,682 6.9564 7,179 104.3460 749,079
2021-08-30 CLSD WHITMORE BRADFORD T 99,400 7.0634 6,627 105.9510 702,102

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CLSDQ / Clearside Biomedical, Inc. Insider Trades
Compras Internas SLSN / Solesence, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CLSDQ / Clearside Biomedical, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Máx		 Preço em
Máx		 Lucro
Máx ($)		 Retorno Máx (%)
2025-05-29 SLSN WHITMORE BRADFORD T 2,500,000 4.2000 2,500,000 4.2000 10,500,000 22 5.2100 2,525,000 24.05
2025-05-29 SLSN WHITMORE BRADFORD T 4,189,000 4.2000 4,189,000 4.2000 17,593,800
2024-02-08 NANX WHITMORE BRADFORD T 2,791,725 0.4000 2,791,725 0.4000 1,116,690
2024-02-08 NANX WHITMORE BRADFORD T 952,697 0.4000 952,697 0.4000 381,079
2024-02-08 NANX WHITMORE BRADFORD T 74,105 0.4000 74,105 0.4000 29,642
2024-02-08 NANX WHITMORE BRADFORD T 6,337 0.4000 6,337 0.4000 2,535
2023-08-23 NANX WHITMORE BRADFORD T 2,100 1.1163 2,100 1.1163 2,344
2023-08-22 NANX WHITMORE BRADFORD T 39,549 0.9091 39,549 0.9091 35,954
2023-08-21 NANX WHITMORE BRADFORD T 44,198 0.9186 44,198 0.9186 40,600
2023-06-01 NANX WHITMORE BRADFORD T 500 1.2050 500 1.2050 602
2023-05-31 NANX WHITMORE BRADFORD T 7,700 1.1791 7,700 1.1791 9,079
2023-05-30 NANX WHITMORE BRADFORD T 8,200 1.1764 8,200 1.1764 9,646
2023-05-19 NANX WHITMORE BRADFORD T 5,650 1.1924 5,650 1.1924 6,737
2023-05-18 NANX WHITMORE BRADFORD T 8,200 1.0416 8,200 1.0416 8,541
2023-05-17 NANX WHITMORE BRADFORD T 53,040 0.7715 53,040 0.7715 40,920
2022-12-15 NANX WHITMORE BRADFORD T 300,488 1.1002 300,488 1.1002 330,597
2022-12-08 NANX WHITMORE BRADFORD T 92,000 1.1634 92,000 1.1634 107,033
2022-12-07 NANX WHITMORE BRADFORD T 450 1.1700 450 1.1700 526
2022-12-06 NANX WHITMORE BRADFORD T 86,318 1.2200 86,318 1.2200 105,308
2022-11-18 NANX WHITMORE BRADFORD T 73,400 1.4000 73,400 1.4000 102,760
2022-11-17 NANX WHITMORE BRADFORD T 47,160 1.3799 47,160 1.3799 65,076
2022-11-16 NANX WHITMORE BRADFORD T 12,625 1.3990 12,625 1.3990 17,662
2021-12-21 NANX WHITMORE BRADFORD T 7,731,573 4.1856 7,731,573 4.1856 32,361,272
2019-05-13 NANX WHITMORE BRADFORD T 4,189,000 0.4000 4,189,000 0.4000 1,675,600
2017-12-19 NANX WHITMORE BRADFORD T 2,500,000 0.4000 2,500,000 0.4000 1,000,000
2016-11-11 NANX WHITMORE BRADFORD T 5,228 0.6500 5,228 0.6500 3,398
2016-11-11 NANX WHITMORE BRADFORD T 10,000 0.6450 10,000 0.6450 6,450
2016-11-11 NANX WHITMORE BRADFORD T 10,000 0.6439 10,000 0.6439 6,439
2016-11-11 NANX WHITMORE BRADFORD T 1,000 0.6400 1,000 0.6400 640
2016-11-11 NANX WHITMORE BRADFORD T 1,250 0.6240 1,250 0.6240 780
2016-11-11 NANX WHITMORE BRADFORD T 5,200 0.6000 5,200 0.6000 3,120
2016-06-07 NANX WHITMORE BRADFORD T 10,000 0.5500 10,000 0.5500 5,500
2016-06-07 NANX WHITMORE BRADFORD T 13,600 0.5500 13,600 0.5500 7,480
2016-06-07 NANX WHITMORE BRADFORD T 6,400 0.5499 6,400 0.5499 3,519
2016-06-07 NANX WHITMORE BRADFORD T 200 0.5300 200 0.5300 106
2016-06-02 NANX WHITMORE BRADFORD T 10,200 0.5089 10,200 0.5089 5,191
2016-06-01 NANX WHITMORE BRADFORD T 100 0.5050 100 0.5050 50
2016-06-01 NANX WHITMORE BRADFORD T 4,735 0.5049 4,735 0.5049 2,391
2016-05-31 NANX WHITMORE BRADFORD T 5,013 0.5050 5,013 0.5050 2,532
2016-05-10 NANX WHITMORE BRADFORD T 2,500 0.5050 2,500 0.5050 1,262
2016-05-05 NANX WHITMORE BRADFORD T 250 0.5000 250 0.5000 125
2016-05-04 NANX WHITMORE BRADFORD T 8,350 0.5000 8,350 0.5000 4,175
2016-05-04 NANX WHITMORE BRADFORD T 5,561 0.5200 5,561 0.5200 2,892
2016-05-04 NANX WHITMORE BRADFORD T 1,600 0.5150 1,600 0.5150 824
2016-05-03 NANX WHITMORE BRADFORD T 33,842 0.5000 33,842 0.5000 16,921
2016-05-03 NANX WHITMORE BRADFORD T 2,500 0.4900 2,500 0.4900 1,225
2016-05-02 NANX WHITMORE BRADFORD T 5,000 0.5000 5,000 0.5000 2,500
2016-05-02 NANX WHITMORE BRADFORD T 2,500 0.4900 2,500 0.4900 1,225
2016-05-02 NANX WHITMORE BRADFORD T 13,377 0.4700 13,377 0.4700 6,287
2016-02-10 NANX WHITMORE BRADFORD T 2,600,000 0.3800 2,600,000 0.3800 988,000
2012-09-12 NANX WHITMORE BRADFORD T 2,421,918 0.3300 2,421,918 0.3300 799,233
2012-03-22 NANX WHITMORE BRADFORD T 20,900 0.3100 20,900 0.3100 6,479
2012-03-22 NANX WHITMORE BRADFORD T 121,922 0.3200 121,922 0.3200 39,015
2012-03-21 NANX WHITMORE BRADFORD T 5,000 0.3000 5,000 0.3000 1,500
2012-03-21 NANX WHITMORE BRADFORD T 74,501 0.2800 74,501 0.2800 20,860
2012-03-21 NANX WHITMORE BRADFORD T 5,000 0.2790 5,000 0.2790 1,395
2012-03-21 NANX WHITMORE BRADFORD T 10,000 0.2510 10,000 0.2510 2,510
2012-03-14 NANX WHITMORE BRADFORD T 1,152,002 0.3800 1,152,002 0.3800 437,761
2012-01-03 NANX WHITMORE BRADFORD T 39,500 0.4350 39,500 0.4350 17,182

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

SLSN / Solesence, Inc. Insider Trades
Vendas Internas SLSN / Solesence, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CLSDQ / Clearside Biomedical, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
2025-05-29 SLSN WHITMORE BRADFORD T 2,500,000 4.2000 2,500,000 4.2000 10,500,000 293 0.8106 -8,473,500 -80.70
2025-05-29 SLSN WHITMORE BRADFORD T 4,189,000 4.2000 4,189,000 4.2000 17,593,800
2021-12-21 NANX WHITMORE BRADFORD T 7,731,573 4.1856 7,731,573 4.1856 32,361,272
2013-05-06 NANX WHITMORE BRADFORD T 254,582 0.3400 254,582 0.3400 86,558
2013-05-06 NANX WHITMORE BRADFORD T 618 0.3500 618 0.3500 216
2012-09-12 NANX WHITMORE BRADFORD T 2,421,918 0.3300 2,421,918 0.3300 799,233
2012-03-14 NANX WHITMORE BRADFORD T 1,152,002 0.3800 1,152,002 0.3800 437,761

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

SLSN / Solesence, Inc. Insider Trades
Compras Internas ULBI / Ultralife Corporation - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CLSDQ / Clearside Biomedical, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Máx		 Preço em
Máx		 Lucro
Máx ($)		 Retorno Máx (%)
2026-05-26 ULBI WHITMORE BRADFORD T 67,302 6.8137 67,302 6.8137 458,576 2 7.7600 63,689 13.89
2026-05-22 ULBI WHITMORE BRADFORD T 8,700 6.3295 8,700 6.3295 55,067
2026-05-21 ULBI WHITMORE BRADFORD T 32,876 6.1343 32,876 6.1343 201,671
2026-03-16 ULBI WHITMORE BRADFORD T 53,131 6.7590 53,131 6.7590 359,112
2026-03-13 ULBI WHITMORE BRADFORD T 100,640 6.3244 100,640 6.3244 636,488
2026-03-12 ULBI WHITMORE BRADFORD T 33,741 5.9663 33,741 5.9663 201,309
2025-12-16 ULBI WHITMORE BRADFORD T 28,588 5.7026 28,588 5.7026 163,026
2025-12-15 ULBI WHITMORE BRADFORD T 14,882 5.6621 14,882 5.6621 84,263
2025-12-12 ULBI WHITMORE BRADFORD T 9,530 5.6257 9,530 5.6257 53,613
2025-11-19 ULBI WHITMORE BRADFORD T 53,900 4.9706 53,900 4.9706 267,915
2025-08-21 ULBI WHITMORE BRADFORD T 29,766 6.6287 29,766 6.6287 197,310
2025-08-20 ULBI WHITMORE BRADFORD T 13,000 6.5710 13,000 6.5710 85,423
2025-08-19 ULBI WHITMORE BRADFORD T 15,898 6.5648 15,898 6.5648 104,367
2025-06-13 ULBI WHITMORE BRADFORD T 10,000 7.6392 10,000 7.6392 76,392
2025-05-23 ULBI WHITMORE BRADFORD T 11,980 5.4072 11,980 5.4072 64,778
2025-05-15 ULBI WHITMORE BRADFORD T 2,140 5.7169 2,140 5.7169 12,234
2025-05-14 ULBI WHITMORE BRADFORD T 16,063 5.4715 16,063 5.4715 87,889
2025-05-13 ULBI WHITMORE BRADFORD T 8,957 5.3983 8,957 5.3983 48,353
2023-12-08 ULBI WHITMORE BRADFORD T 7,000 7.1913 7,000 7.1913 50,339
2023-12-06 ULBI WHITMORE BRADFORD T 8,877 6.8271 8,877 6.8271 60,604
2023-11-29 ULBI WHITMORE BRADFORD T 10,740 7.3409 10,740 7.3409 78,841
2023-11-28 ULBI WHITMORE BRADFORD T 11,160 7.0813 11,160 7.0813 79,027
2023-11-27 ULBI WHITMORE BRADFORD T 3,200 7.1196 3,200 7.1196 22,783
2023-11-01 ULBI WHITMORE BRADFORD T 1,100 7.5146 1,100 7.5146 8,266
2023-10-31 ULBI WHITMORE BRADFORD T 2,600 7.3693 2,600 7.3693 19,160
2023-10-30 ULBI WHITMORE BRADFORD T 10,171 7.0362 10,171 7.0362 71,565
2023-09-15 ULBI WHITMORE BRADFORD T 3,741 10.2509 3,741 10.2509 38,349
2023-09-14 ULBI WHITMORE BRADFORD T 1,600 10.3475 1,600 10.3475 16,556
2023-09-13 ULBI WHITMORE BRADFORD T 5,659 10.0209 5,659 10.0209 56,708
2023-06-14 ULBI WHITMORE BRADFORD T 33,797 4.9672 33,797 4.9672 167,876
2023-06-13 ULBI WHITMORE BRADFORD T 33,400 4.9976 33,400 4.9976 166,920
2023-06-12 ULBI WHITMORE BRADFORD T 13,401 4.7235 13,401 4.7235 63,300
2023-06-02 ULBI WHITMORE BRADFORD T 5,964 4.4001 5,964 4.4001 26,242
2023-06-01 ULBI WHITMORE BRADFORD T 20,247 4.3269 20,247 4.3269 87,607
2023-05-31 ULBI WHITMORE BRADFORD T 7,216 4.2799 7,216 4.2799 30,884
2023-05-30 ULBI WHITMORE BRADFORD T 6,500 4.2925 6,500 4.2925 27,901
2023-05-11 ULBI WHITMORE BRADFORD T 20,256 4.0804 20,256 4.0804 82,653
2023-05-10 ULBI WHITMORE BRADFORD T 3,979 4.0326 3,979 4.0326 16,046
2023-05-09 ULBI WHITMORE BRADFORD T 4,553 3.9720 4,553 3.9720 18,085
2023-03-13 ULBI WHITMORE BRADFORD T 14,338 4.0700 14,338 4.0700 58,356
2023-03-10 ULBI WHITMORE BRADFORD T 10,100 4.0490 10,100 4.0490 40,895
2023-03-09 ULBI WHITMORE BRADFORD T 5,562 4.0709 5,562 4.0709 22,642
2022-12-16 ULBI WHITMORE BRADFORD T 7,200 3.9837 7,200 3.9837 28,683
2022-12-15 ULBI WHITMORE BRADFORD T 5,138 3.9410 5,138 3.9410 20,249
2022-12-14 ULBI WHITMORE BRADFORD T 25,694 4.0099 25,694 4.0099 103,030
2022-12-08 ULBI WHITMORE BRADFORD T 28,600 4.1196 28,600 4.1196 117,821
2022-12-07 ULBI WHITMORE BRADFORD T 19,600 3.9681 19,600 3.9681 77,775
2022-12-06 ULBI WHITMORE BRADFORD T 20,996 3.9595 20,996 3.9595 83,134
2022-08-18 ULBI WHITMORE BRADFORD T 17,700 4.6447 17,700 4.6447 82,211
2022-08-17 ULBI WHITMORE BRADFORD T 16,400 4.5986 16,400 4.5986 75,417
2022-08-04 ULBI WHITMORE BRADFORD T 40,052 4.7253 40,052 4.7253 189,258
2022-08-03 ULBI WHITMORE BRADFORD T 29,100 4.6849 29,100 4.6849 136,331
2022-08-02 ULBI WHITMORE BRADFORD T 30,848 4.5999 30,848 4.5999 141,898
2022-06-08 ULBI WHITMORE BRADFORD T 30,690 5.1989 30,690 5.1989 159,554
2022-06-06 ULBI WHITMORE BRADFORD T 12,280 4.8614 12,280 4.8614 59,698
2022-02-28 ULBI WHITMORE BRADFORD T 30 5.2200 30 5.2200 157
2022-02-25 ULBI WHITMORE BRADFORD T 100 5.1400 100 5.1400 514
2022-02-24 ULBI WHITMORE BRADFORD T 54,900 4.4448 54,900 4.4448 244,020
2021-12-17 ULBI WHITMORE BRADFORD T 53,251 5.5703 53,251 5.5703 296,624
2021-08-04 ULBI WHITMORE BRADFORD T 7,687 7.9691 7,687 7.9691 61,258
2021-08-03 ULBI WHITMORE BRADFORD T 12,400 7.8516 12,400 7.8516 97,360
2021-08-02 ULBI WHITMORE BRADFORD T 5,113 7.9509 5,113 7.9509 40,653
2020-05-14 ULBI WHITMORE BRADFORD T 5,000 7.4293 5,000 7.4293 37,146
2020-05-11 ULBI WHITMORE BRADFORD T 1,379 8.3000 1,379 8.3000 11,446
2020-05-08 ULBI WHITMORE BRADFORD T 3,800 8.1779 3,800 8.1779 31,076
2020-05-07 ULBI WHITMORE BRADFORD T 3,631 8.0534 3,631 8.0534 29,242
2020-05-06 ULBI WHITMORE BRADFORD T 2,678 8.3623 2,678 8.3623 22,394
2020-05-05 ULBI WHITMORE BRADFORD T 2,978 8.3831 2,978 8.3831 24,965
2020-05-04 ULBI WHITMORE BRADFORD T 5,534 7.6419 5,534 7.6419 42,290
2020-03-17 ULBI WHITMORE BRADFORD T 30,092 5.3673 30,092 5.3673 161,513
2020-03-17 ULBI WHITMORE BRADFORD T 2,233 6.1893 2,233 6.1893 13,821
2020-03-16 ULBI WHITMORE BRADFORD T 1,703 5.2343 1,703 5.2343 8,914
2020-03-13 ULBI WHITMORE BRADFORD T 15,972 5.6857 15,972 5.6857 90,812
2020-02-19 ULBI WHITMORE BRADFORD T 58,845 7.1591 58,845 7.1591 421,277
2020-02-18 ULBI WHITMORE BRADFORD T 41,155 7.3489 41,155 7.3489 302,444
2017-02-24 ULBI WHITMORE BRADFORD T 7,000 5.4500 7,000 5.4500 38,150
2017-02-24 ULBI WHITMORE BRADFORD T 5,834 5.4000 5,834 5.4000 31,504
2017-02-24 ULBI WHITMORE BRADFORD T 100 5.3750 100 5.3750 538
2017-02-14 ULBI WHITMORE BRADFORD T 6,069 5.4500 6,069 5.4500 33,076
2017-02-13 ULBI WHITMORE BRADFORD T 15,700 5.2000 15,700 5.2000 81,640
2017-02-13 ULBI WHITMORE BRADFORD T 15,600 5.1500 15,600 5.1500 80,340
2017-02-13 ULBI WHITMORE BRADFORD T 4,669 5.1450 4,669 5.1450 24,022
2017-02-13 ULBI WHITMORE BRADFORD T 700 5.1435 700 5.1435 3,600
2017-02-13 ULBI WHITMORE BRADFORD T 5,900 5.1000 5,900 5.1000 30,090
2016-11-15 ULBI WHITMORE BRADFORD T 11,450 4.2500 11,450 4.2500 48,662
2016-11-15 ULBI WHITMORE BRADFORD T 957 4.2000 957 4.2000 4,019
2016-11-11 ULBI WHITMORE BRADFORD T 5,800 4.2500 5,800 4.2500 24,650
2016-11-11 ULBI WHITMORE BRADFORD T 100 4.2458 100 4.2458 425
2016-11-11 ULBI WHITMORE BRADFORD T 14,100 4.2450 14,100 4.2450 59,854
2016-11-11 ULBI WHITMORE BRADFORD T 700 4.2200 700 4.2200 2,954
2016-09-09 ULBI WHITMORE BRADFORD T 48,800 4.1500 48,800 4.1500 202,520
2016-09-09 ULBI WHITMORE BRADFORD T 400 4.1400 400 4.1400 1,656
2016-09-09 ULBI WHITMORE BRADFORD T 600 4.1300 600 4.1300 2,478
2016-09-09 ULBI WHITMORE BRADFORD T 200 4.1200 200 4.1200 824
2016-08-04 ULBI WHITMORE BRADFORD T 1,400 4.3800 1,400 4.3800 6,132
2016-08-04 ULBI WHITMORE BRADFORD T 200 4.3600 200 4.3600 872
2016-08-04 ULBI WHITMORE BRADFORD T 546 4.3400 546 4.3400 2,370
2016-08-04 ULBI WHITMORE BRADFORD T 15 4.3200 15 4.3200 65
2016-08-04 ULBI WHITMORE BRADFORD T 5 4.3100 5 4.3100 22
2016-08-04 ULBI WHITMORE BRADFORD T 1,110 4.3000 1,110 4.3000 4,773
2016-08-04 ULBI WHITMORE BRADFORD T 22,600 4.2500 22,600 4.2500 96,050
2016-08-04 ULBI WHITMORE BRADFORD T 1,100 4.2000 1,100 4.2000 4,620
2016-08-04 ULBI WHITMORE BRADFORD T 100 4.1300 100 4.1300 413
2016-08-04 ULBI WHITMORE BRADFORD T 100 4.1100 100 4.1100 411
2016-08-03 ULBI WHITMORE BRADFORD T 3,026 4.2700 3,026 4.2700 12,921
2016-08-03 ULBI WHITMORE BRADFORD T 1,100 4.2000 1,100 4.2000 4,620
2016-08-02 ULBI WHITMORE BRADFORD T 3,248 4.0900 3,248 4.0900 13,284
2016-08-02 ULBI WHITMORE BRADFORD T 100 4.0800 100 4.0800 408
2016-08-02 ULBI WHITMORE BRADFORD T 2,257 4.0700 2,257 4.0700 9,186
2016-08-02 ULBI WHITMORE BRADFORD T 2,350 4.0600 2,350 4.0600 9,541
2016-08-02 ULBI WHITMORE BRADFORD T 4,296 4.0500 4,296 4.0500 17,399
2016-08-02 ULBI WHITMORE BRADFORD T 100 4.0400 100 4.0400 404
2016-08-02 ULBI WHITMORE BRADFORD T 2,266 4.0300 2,266 4.0300 9,132
2016-08-02 ULBI WHITMORE BRADFORD T 4,066 4.0200 4,066 4.0200 16,345

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ULBI / Ultralife Corporation Insider Trades
Vendas Internas ULBI / Ultralife Corporation - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CLSDQ / Clearside Biomedical, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ULBI / Ultralife Corporation Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Bradford T Whitmore conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual		 Preço
da Ação		 Valor
da Transação		 Valor
Restante
2026-05-26 2026-05-26 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 67,302 2,050,637 3.39 6.81 458,576 13,972,425
2026-05-26 2026-05-22 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 8,700 1,983,335 0.44 6.33 55,067 12,553,519
2026-05-26 2026-05-21 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 32,876 1,974,635 1.69 6.13 201,671 12,113,003
2026-03-16 2026-03-16 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 53,131 1,941,759 2.81 6.76 359,112 13,124,349
2026-03-16 2026-03-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 100,640 1,888,628 5.63 6.32 636,488 11,944,439
2026-03-16 2026-03-12 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 33,741 1,787,988 1.92 5.97 201,309 10,667,673
2025-12-16 2025-12-16 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 28,588 1,235,631 2.37 5.70 163,026 7,046,309
2025-12-16 2025-12-15 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 14,882 1,207,043 1.25 5.66 84,263 6,834,398
2025-12-16 2025-12-12 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 9,530 1,192,161 0.81 5.63 53,613 6,706,740
2025-11-21 2025-11-19 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 53,900 1,182,631 4.78 4.97 267,915 5,878,386
2025-08-21 2025-08-21 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 29,766 1,128,731 2.71 6.63 197,310 7,482,019
2025-08-21 2025-08-20 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 13,000 1,098,965 1.20 6.57 85,423 7,221,299
2025-08-21 2025-08-19 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 15,898 1,085,965 1.49 6.56 104,367 7,129,143
2025-06-13 2025-06-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 10,000 1,070,067 0.94 7.64 76,392 8,174,456
2025-06-02 2025-05-29 4 SLSN SOLESENCE, INC.
Common Stock 		S - Sale -4,189,000 18,669,879 -18.33 4.20 -17,593,800 78,413,492
2025-06-02 2025-05-29 4 SLSN SOLESENCE, INC.
Common Stock 		S - Sale -2,500,000 22,858,879 -9.86 4.20 -10,500,000 96,007,292
2025-06-02 2025-05-29 4 SLSN SOLESENCE, INC.
Common Stock 		P - Purchase 4,189,000 30,373,270 16.00 4.20 17,593,800 127,567,734
2025-06-02 2025-05-29 4 SLSN SOLESENCE, INC.
Common Stock 		P - Purchase 2,500,000 26,184,270 10.56 4.20 10,500,000 109,973,934
2025-05-28 2025-05-23 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 11,980 1,060,067 1.14 5.41 64,778 5,731,994
2025-05-15 2025-05-15 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 2,140 1,048,087 0.20 5.72 12,234 5,991,809
2025-05-15 2025-05-14 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 16,063 1,045,947 1.56 5.47 87,889 5,722,899
2025-05-15 2025-05-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 8,957 1,029,884 0.88 5.40 48,353 5,559,623
2024-06-26 2024-06-25 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		C - Conversion 15,000,000 23,684,270 172.73
2024-02-12 2024-02-08 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 6,337 57,791 12.32 0.40 2,535 23,116
2024-02-12 2024-02-08 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 74,105 675,515 12.32 0.40 29,642 270,206
2024-02-12 2024-02-08 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 952,697 8,684,270 12.32 0.40 381,079 3,473,708
2024-02-12 2024-02-08 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,791,725 25,467,020 12.31 0.40 1,116,690 10,186,808
2024-02-09 2024-02-07 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 444,444 4,495,034 10.97 1.35 599,999 6,068,296
2023-12-08 2023-12-08 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 7,000 1,226,842 0.57 7.19 50,339 8,822,589
2023-12-08 2023-12-06 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 8,877 1,219,842 0.73 6.83 60,604 8,327,983
2023-11-29 2023-11-29 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 10,740 1,210,965 0.89 7.34 78,841 8,889,573
2023-11-29 2023-11-28 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 11,160 1,200,225 0.94 7.08 79,027 8,499,153
2023-11-29 2023-11-27 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 3,200 1,189,065 0.27 7.12 22,783 8,465,667
2023-11-01 3 CLSD Clearside Biomedical, Inc.
Common Stock 		3,914,812
2023-11-01 3 CLSD Clearside Biomedical, Inc.
Common Stock 		2,350,152
2023-11-01 2023-11-01 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 64,366 4,050,590 1.61 0.74 47,901 3,014,449
2023-11-01 2023-10-31 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 70,812 3,986,224 1.81 0.73 51,537 2,901,174
2023-11-01 2023-10-30 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 600 3,915,412 0.02 0.68 411 2,682,057
2023-11-01 2023-11-01 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 1,100 1,185,865 0.09 7.51 8,266 8,911,301
2023-11-01 2023-10-31 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 2,600 1,184,765 0.22 7.37 19,160 8,730,889
2023-11-01 2023-10-30 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 10,171 1,182,165 0.87 7.04 71,565 8,317,949
2023-09-15 2023-09-15 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 3,741 1,171,994 0.32 10.25 38,349 12,013,993
2023-09-15 2023-09-14 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 1,600 1,168,253 0.14 10.35 16,556 12,088,498
2023-09-15 2023-09-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 5,659 1,166,653 0.49 10.02 56,708 11,690,913
2023-08-23 2023-08-23 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,100 30,406,868 0.01 1.12 2,344 33,943,187
2023-08-23 2023-08-22 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 39,549 30,404,768 0.13 0.91 35,954 27,640,975
2023-08-23 2023-08-21 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 44,198 30,365,219 0.15 0.92 40,600 27,893,490
2023-06-14 2023-06-14 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 33,797 1,160,994 3.00 4.97 167,876 5,766,889
2023-06-14 2023-06-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 33,400 1,127,197 3.05 5.00 166,920 5,633,280
2023-06-14 2023-06-12 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 13,401 1,093,797 1.24 4.72 63,300 5,166,550
2023-06-05 2023-06-02 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 5,964 1,080,396 0.56 4.40 26,242 4,753,850
2023-06-01 2023-06-01 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 500 30,321,021 0.00 1.20 602 36,536,830
2023-06-01 2023-05-31 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 7,700 30,320,521 0.03 1.18 9,079 35,750,926
2023-06-01 2023-05-30 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 8,200 30,312,821 0.03 1.18 9,646 35,660,003
2023-06-01 2023-06-01 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 20,247 1,074,432 1.92 4.33 87,607 4,648,960
2023-06-01 2023-05-31 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 7,216 1,054,185 0.69 4.28 30,884 4,511,806
2023-06-01 2023-05-30 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 6,500 1,046,969 0.62 4.29 27,901 4,494,114
2023-05-19 2023-05-19 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,650 30,304,621 0.02 1.19 6,737 36,135,230
2023-05-19 2023-05-18 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 8,200 30,298,971 0.03 1.04 8,541 31,559,408
2023-05-19 2023-05-17 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 53,040 30,290,771 0.18 0.77 40,920 23,369,330
2023-05-11 2023-05-11 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 20,256 1,040,469 1.99 4.08 82,653 4,245,530
2023-05-11 2023-05-10 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 3,979 1,020,213 0.39 4.03 16,046 4,114,111
2023-05-11 2023-05-09 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 4,553 1,016,234 0.45 3.97 18,085 4,036,481
2023-03-13 2023-03-13 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 14,338 1,011,681 1.44 4.07 58,356 4,117,542
2023-03-13 2023-03-10 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 10,100 997,343 1.02 4.05 40,895 4,038,242
2023-03-13 2023-03-09 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 5,562 987,243 0.57 4.07 22,642 4,018,968
2022-12-16 2022-12-15 4/A NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 300,488 30,237,731 1.00 1.10 330,597 33,267,552
2022-12-16 2022-12-16 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 7,200 981,681 0.74 3.98 28,683 3,910,723
2022-12-16 2022-12-15 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 5,138 974,481 0.53 3.94 20,249 3,840,430
2022-12-16 2022-12-14 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 25,694 969,343 2.72 4.01 103,030 3,886,968
2022-12-15 2022-12-15 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 300,488 30,237,731 1.00 1.10 330,597 33,267,552
2022-12-08 2022-12-08 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 92,000 29,937,243 0.31 1.16 107,033 34,828,989
2022-12-08 2022-12-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 450 29,845,243 0.00 1.17 526 34,918,934
2022-12-08 2022-12-06 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 86,318 29,844,793 0.29 1.22 105,308 36,410,647
2022-12-08 2022-12-08 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 28,600 943,649 3.13 4.12 117,821 3,887,456
2022-12-08 2022-12-07 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 19,600 915,049 2.19 3.97 77,775 3,631,006
2022-12-08 2022-12-06 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 20,996 895,449 2.40 3.96 83,134 3,545,530
2022-11-18 2022-11-18 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 73,400 29,758,475 0.25 1.40 102,760 41,661,865
2022-11-18 2022-11-17 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 47,160 29,685,075 0.16 1.38 65,076 40,962,435
2022-11-18 2022-11-16 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 12,625 29,637,915 0.04 1.40 17,662 41,463,443
2022-08-19 2022-08-18 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 17,700 874,453 2.07 4.64 82,211 4,061,572
2022-08-19 2022-08-17 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 16,400 856,753 1.95 4.60 75,417 3,939,864
2022-08-04 2022-08-04 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 40,052 840,353 5.00 4.73 189,258 3,970,920
2022-08-04 2022-08-03 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 29,100 800,301 3.77 4.68 136,331 3,749,330
2022-08-04 2022-08-02 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 30,848 771,201 4.17 4.60 141,898 3,547,447
2022-06-08 2022-06-08 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 30,690 740,353 4.32 5.20 159,554 3,849,021
2022-06-08 2022-06-06 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 12,280 709,663 1.76 4.86 59,698 3,449,956
2022-02-28 2022-02-28 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 30 697,383 0.00 5.22 157 3,640,339
2022-02-28 2022-02-25 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 100 697,353 0.01 5.14 514 3,584,394
2022-02-28 2022-02-24 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 54,900 697,253 8.55 4.44 244,020 3,099,150
2021-12-23 2021-12-21 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 7,731,573 7,731,573 4.19 32,361,272 32,361,272
2021-12-23 2021-12-21 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		S - Sale -7,731,573 21,893,717 -26.10 4.19 -32,361,272 91,638,342
2021-12-20 2021-12-17 4 ULBI ULTRALIFE CORP
Common Stock 		P - Purchase 53,251 642,353 9.04 5.57 296,624 3,578,099
2021-09-01 2021-09-01 4 CLSD Clearside Biomedical, Inc.
Common Stock 		S - Sale -213,203 2,415,056 -8.11 6.89 -1,469,246 16,642,875
2021-09-01 2021-08-31 4 CLSD Clearside Biomedical, Inc.
Common Stock 		S - Sale -107,682 2,628,259 -3.94 6.96 -749,079 18,283,221
2021-09-01 2021-08-30 4 CLSD Clearside Biomedical, Inc.
Common Stock 		S - Sale -99,400 2,735,941 -3.51 7.06 -702,102 19,325,046
2021-08-04 2021-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 7,687 589,102 1.32 7.97 61,258 4,694,613
2021-08-04 2021-08-03 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 12,400 581,415 2.18 7.85 97,360 4,565,038
2021-08-04 2021-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,113 569,015 0.91 7.95 40,653 4,524,181
2021-05-11 2021-05-07 4 NANX NANOPHASE TECHNOLOGIES Corp
2% Second Secured Convertible Note 		C - Conversion -2,019,111 0 -100.00 0.20 -403,822
2021-05-11 2021-05-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		C - Conversion 10,095,555 29,625,290 51.69 0.20 2,019,111 5,925,058
2021-01-07 2021-01-06 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 350,750 3,529,845 11.03 2.85 999,988 10,063,588
2020-12-28 2020-12-24 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 51,195 3,179,095 1.64 1.95 99,897 6,203,368
2020-12-02 2020-12-02 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 53,900 3,127,900 1.75 1.95 105,051 6,096,277
2020-11-24 2020-11-24 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 62,000 3,074,000 2.06 1.65 102,046 5,059,497
2020-11-16 2020-11-16 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 62,000 3,012,000 2.10 1.69 104,929 5,097,509
2020-10-01 2020-09-29 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		J - Other -2,433,300 0 -100.00
2020-10-01 2020-09-29 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		J - Other 2,433,300 19,529,735 14.23
2020-08-13 2020-08-13 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 50,000 2,950,000 1.72 1.65 82,560 4,871,040
2020-08-13 2020-08-12 4 CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 300,000 2,900,000 11.54 1.63 489,120 4,728,160
2020-08-13 2020-08-13 4/A CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 50,000 2,950,000 1.72 1.65 82,560 4,871,040
2020-08-13 2020-08-12 4/A CLSD Clearside Biomedical, Inc.
Common Stock 		P - Purchase 300,000 2,900,000 11.54 1.63 489,120 4,728,160
2020-05-18 2020-05-14 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,000 563,902 0.89 7.43 37,146 4,189,397
2020-05-11 2020-05-11 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,379 558,902 0.25 8.30 11,446 4,638,887
2020-05-11 2020-05-08 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,800 557,523 0.69 8.18 31,076 4,559,367
2020-05-11 2020-05-07 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,631 553,723 0.66 8.05 29,242 4,459,353
2020-05-06 2020-05-06 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,678 550,092 0.49 8.36 22,394 4,600,034
2020-05-06 2020-05-05 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,978 547,414 0.55 8.38 24,965 4,589,026
2020-05-06 2020-05-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,534 544,436 1.03 7.64 42,290 4,160,525
2020-03-17 2020-03-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,233 538,902 0.42 6.19 13,821 3,335,426
2020-03-17 2020-03-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 30,092 536,669 5.94 5.37 161,513 2,880,464
2020-03-17 2020-03-16 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,703 506,577 0.34 5.23 8,914 2,651,576
2020-03-17 2020-03-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 15,972 504,874 3.27 5.69 90,812 2,870,562
2020-02-20 2020-02-19 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 58,845 488,902 13.68 7.16 421,277 3,500,098
2020-02-20 2020-02-18 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 41,155 430,057 10.58 7.35 302,444 3,160,446
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,035,341
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,270,682
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,035,341
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,270,682
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,035,341
2019-11-26 3 CLSD Clearside Biomedical, Inc.
Common Stock 		8,270,682
2019-11-15 2019-11-13 4 NANX NANOPHASE TECHNOLOGIES Corp
2% Second Secured Convertible Note 		P - Purchase 2,000,000 2,000,000.00 4,000,000,000,000
2019-05-15 2019-05-13 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 4,189,000 17,096,435 32.45 0.40 1,675,600 6,838,574
2017-12-21 2017-12-19 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,500,000 12,907,435 24.02 0.40 1,000,000 5,162,974
2017-02-28 2017-02-24 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 388,902 0.03 5.38 538 2,090,348
2017-02-28 2017-02-24 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,834 388,802 1.52 5.40 31,504 2,099,531
2017-02-28 2017-02-24 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 7,000 382,968 1.86 5.45 38,150 2,087,176
2017-02-15 2017-02-14 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 6,069 375,968 1.64 5.45 33,076 2,049,026
2017-02-15 2017-02-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,900 369,899 1.62 5.10 30,090 1,886,485
2017-02-15 2017-02-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 700 363,999 0.19 5.14 3,600 1,872,229
2017-02-15 2017-02-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 4,669 363,299 1.30 5.14 24,022 1,869,173
2017-02-15 2017-02-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 15,600 358,630 4.55 5.15 80,340 1,846,944
2017-02-15 2017-02-13 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 15,700 343,030 4.80 5.20 81,640 1,783,756
2017-01-11 2016-12-27 5 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		W - Other 3,272 3,272
2017-01-11 2016-12-27 5 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		W - Other 51,454 51,454
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,200 10,407,435 0.05 0.60 3,120 6,244,461
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 1,250 10,402,235 0.01 0.62 780 6,490,995
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 1,000 10,400,985 0.01 0.64 640 6,656,630
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 10,000 10,399,985 0.10 0.64 6,439 6,696,550
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 10,000 10,389,985 0.10 0.64 6,450 6,701,540
2016-11-15 2016-11-11 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,228 10,379,985 0.05 0.65 3,398 6,746,990
2016-11-15 2016-11-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 957 327,330 0.29 4.20 4,019 1,374,786
2016-11-15 2016-11-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 11,450 326,373 3.64 4.25 48,662 1,387,085
2016-11-15 2016-11-11 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 700 314,923 0.22 4.22 2,954 1,328,975
2016-11-15 2016-11-11 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 14,100 314,223 4.70 4.24 59,854 1,333,877
2016-11-15 2016-11-11 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 300,123 0.03 4.25 425 1,274,262
2016-11-15 2016-11-11 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,800 300,023 1.97 4.25 24,650 1,275,098
2016-09-09 2016-09-09 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 200 294,223 0.07 4.12 824 1,212,199
2016-09-09 2016-09-09 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 600 294,023 0.20 4.13 2,478 1,214,315
2016-09-09 2016-09-09 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 400 293,423 0.14 4.14 1,656 1,214,771
2016-09-09 2016-09-09 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 48,800 293,023 19.98 4.15 202,520 1,216,045
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 244,223 0.04 4.11 411 1,003,757
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 244,123 0.04 4.13 413 1,008,228
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,100 244,023 0.45 4.20 4,620 1,024,897
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 22,600 242,923 10.26 4.25 96,050 1,032,423
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,110 220,323 0.51 4.30 4,773 947,389
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5 219,213 0.00 4.31 22 944,808
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 15 219,208 0.01 4.32 65 946,979
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 546 219,193 0.25 4.34 2,370 951,298
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 200 218,647 0.09 4.36 872 953,301
2016-08-04 2016-08-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,400 218,447 0.65 4.38 6,132 956,798
2016-08-04 2016-08-03 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,100 217,047 0.51 4.20 4,620 911,597
2016-08-04 2016-08-03 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,026 215,947 1.42 4.27 12,921 922,094
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 4,066 212,921 1.95 4.02 16,345 855,942
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,266 208,855 1.10 4.03 9,132 841,686
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 206,589 0.05 4.04 404 834,620
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 4,296 206,489 2.12 4.05 17,399 836,280
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,350 202,193 1.18 4.06 9,541 820,904
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,257 199,843 1.14 4.07 9,186 813,361
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 100 197,586 0.05 4.08 408 806,151
2016-08-04 2016-08-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,248 197,486 1.67 4.09 13,284 807,718
2016-06-08 2016-06-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 200 10,374,757 0.00 0.53 106 5,498,621
2016-06-08 2016-06-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 6,400 10,374,557 0.06 0.55 3,519 5,704,969
2016-06-08 2016-06-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 13,600 10,368,157 0.13 0.55 7,480 5,702,486
2016-06-08 2016-06-07 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 10,000 10,354,557 0.10 0.55 5,500 5,695,006
2016-06-02 2016-06-02 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 10,200 10,344,557 0.10 0.51 5,191 5,264,345
2016-06-02 2016-06-01 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 4,735 10,334,357 0.05 0.50 2,391 5,217,817
2016-06-02 2016-06-01 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 100 10,329,622 0.00 0.50 50 5,216,459
2016-06-02 2016-05-31 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,013 10,329,522 0.05 0.50 2,532 5,216,409
2016-05-10 2016-05-10 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,500 10,324,509 0.02 0.50 1,262 5,213,877
2016-05-09 2016-05-05 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 250 10,322,009 0.00 0.50 125 5,161,004
2016-05-04 2016-05-04 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 1,600 10,321,759 0.02 0.52 824 5,315,706
2016-05-04 2016-05-04 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,561 10,320,159 0.05 0.52 2,892 5,366,483
2016-05-04 2016-05-04 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 8,350 10,314,598 0.08 0.50 4,175 5,157,299
2016-05-04 2016-05-03 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,500 10,306,248 0.02 0.49 1,225 5,050,062
2016-05-04 2016-05-03 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 33,842 10,303,748 0.33 0.50 16,921 5,151,874
2016-05-04 2016-05-02 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 13,377 10,269,906 0.13 0.47 6,287 4,826,856
2016-05-04 2016-05-02 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,500 10,256,529 0.02 0.49 1,225 5,025,699
2016-05-04 2016-05-02 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 5,000 10,254,029 0.05 0.50 2,500 5,127,014
2016-02-10 2016-02-10 4 NANX NANOPHASE TECHNOLOGIES Corp
Common Stock 		P - Purchase 2,600,000 10,249,029 33.99 0.38 988,000 3,894,631
2014-08-18 2014-08-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 4,970 194,238 2.63
2014-05-19 2014-05-19 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 4,133 189,268 2.23
2014-02-18 2014-02-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 4,275 185,135 2.36
2013-11-15 2013-11-15 4 ULBI ULTRALIFE CORP
Common Stock 		A - Award 4,573 180,860 2.59
2013-08-15 2013-08-15 4 ULBI ULTRALIFE CORP
Common Stock 		A - Award 4,460 176,287 2.60
2013-05-08 2013-05-06 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		S - Sale -618 7,649,029 -0.01 0.35 -216 2,677,160
2013-05-08 2013-05-06 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		S - Sale -254,582 7,649,647 -3.22 0.34 -86,558 2,600,880
2012-12-17 2012-12-13 4 ULBI ULTRALIFE CORP
Common Stock 		J - Other 4,452,283 4,452,283
2012-12-17 2012-12-13 4 ULBI ULTRALIFE CORP
Common Stock 		J - Other -4,452,283 171,827 -96.28
2012-11-15 2012-11-15 4 ULBI ULTRALIFE CORP
Common Stock 		A - Award 5,556 4,624,110 0.12
2012-09-14 2012-09-12 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		S - Sale -2,421,918 2,433,300 -49.88 0.33 -799,233 802,989
2012-09-14 2012-09-12 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 2,421,918 7,904,229 44.18 0.33 799,233 2,608,396
2012-08-15 2012-08-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 5,243 4,618,554 0.11
2012-05-15 2012-05-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 3,769 4,613,311 0.08
2012-03-23 2012-03-22 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 121,922 2,744,352 4.65 0.32 39,015 878,193
2012-03-23 2012-03-22 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 20,900 2,622,430 0.80 0.31 6,479 812,953
2012-03-23 2012-03-21 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 10,000 2,601,530 0.39 0.25 2,510 652,984
2012-03-23 2012-03-21 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 5,000 2,591,530 0.19 0.28 1,395 723,037
2012-03-23 2012-03-21 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 74,501 2,586,530 2.97 0.28 20,860 724,228
2012-03-23 2012-03-21 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 5,000 2,512,029 0.20 0.30 1,500 753,609
2012-03-16 2012-03-14 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		S - Sale -1,152,002 2,421,918 -32.23 0.38 -437,761 920,329
2012-03-16 2012-03-14 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 1,152,002 2,507,029 85.02 0.38 437,761 952,671
2012-02-15 2012-02-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 3,509 4,609,542 0.08
2012-01-05 2012-01-03 4 NANX NANOPHASE TECHNOLOGIES CORPORATION
Common Stock 		P - Purchase 39,500 1,355,027 3.00 0.44 17,182 589,437
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)